Attached files

file filename
10-Q - Artemis Therapeutics, Inc.zk97513.htm
EX-31.1 - Artemis Therapeutics, Inc.exhibit_31-1.htm
EX-31.2 - Artemis Therapeutics, Inc.exhibit_31-2.htm


                                                                    EXHIBIT 32.1

                                  CERTIFICATION
            PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
             (SUBSECTIONS (A) AND (B) OF SECTION 1350, CHAPTER 63 OF
                          TITLE 18, UNITED STATES CODE)

     Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a)
and (b) of section 1350, chapter 63 of title 18, United States Code), each of
the undersigned officers of InkSure Technologies Inc., a Delaware corporation
(the "Company"), does hereby certify, to such officer's knowledge, that:

     The Form 10-Q for the quarter ended March 31, 2009 (the "Form10-Q") of the
Company fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, and the information contained in the Form 10-Q
fairly presents, in all material respects, the financial condition and results
of operations of the Company.

Dated: November 13, 2009         /s/ Yaron Meerfeld
                                 ------------------------
                                 Yaron Meerfeld, Acting Chief Executive Officer
                                 (Principal Executive Officer)


Dated: November 13, 2009         /s/Tzlil Peker
                                 ---------------------
                                 Tzlil Peker, Chief Financial Officer
                                 (Principal Financial Officer)

A signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.